|March 1, 2016|
|Verastem to Host Conference Call on March 3rd to Discuss Fourth Quarter and Full-Year 2015 Financial Results and Recent Highlights|
BOSTON--(BUSINESS WIRE)--Mar. 1, 2016--
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing
drugs to treat cancer, today announced that the Company will host a
conference call and webcast on Thursday, March 3, 2016 at 8:30 a.m.
Eastern Time to discuss corporate updates and financial results for the
fourth quarter year ended December 31, 2015.
The call can be accessed by dialing (877) 341-5660 (U.S. and Canada) or
(315) 625-3226 (international), and entering passcode 53106888. To
access the live webcast, or the subsequent archived recording, please
use either the following link: http://bit.ly/1oKXlLa
or visit the investors section of the Verastem website at www.verastem.com.
About Verastem, Inc.
Verastem, Inc. (NASDAQ:VSTM) is a biopharmaceutical company focused on
discovering and developing drugs to improve outcomes for patients with
cancer. Our product candidates utilize a multi-faceted approach to treat
cancer by reducing cancer stem cells, enhancing anti-tumor immunity, and
modulating the local tumor microenvironment. Our most advanced clinical
product candidates are the Focal Adhesion Kinase inhibitors, VS-6063 and
VS-4718, and the dual PI3K/mTOR inhibitor, VS-5584. For more
information, please visit www.verastem.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160301005544/en/
Source: Verastem, Inc.
Brian Sullivan, 781-292-4214